Cite
HARVARD Citation
Moosavian, S. et al. (2018). 5TR1 aptamer-PEGylated liposomal doxorubicin enhances cellular uptake and suppresses tumour growth by targeting MUC1 on the surface of cancer cells. Artificial cells, nanomedicine, and biotechnology. pp. 2054-2065. [Online].